227 related articles for article (PubMed ID: 32340100)
1. Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists.
Vasile S; Hallberg A; Sallander J; Hallberg M; Åqvist J; Gutiérrez-de-Terán H
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32340100
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin Peptides as AT2 Receptor Agonists.
Hallberg M; Sävmarker J; Hallberg A
Curr Protein Pept Sci; 2017; 18(8):809-818. PubMed ID: 28164758
[TBL] [Abstract][Full Text] [Related]
3. Update on Angiotensin II Subtype 2 Receptor: Focus on Peptide and Nonpeptide Agonists.
Ranjit A; Khajehpour S; Aghazadeh-Habashi A
Mol Pharmacol; 2021 Jun; 99(6):469-487. PubMed ID: 33795351
[TBL] [Abstract][Full Text] [Related]
4. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
[TBL] [Abstract][Full Text] [Related]
5. Interplay between intracellular loop 1 and helix VIII of the angiotensin II type 2 receptor controls its activation.
Connolly A; Holleran BJ; Simard É; Baillargeon JP; Lavigne P; Leduc R
Biochem Pharmacol; 2019 Oct; 168():330-338. PubMed ID: 31348898
[TBL] [Abstract][Full Text] [Related]
6. Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II.
Magnani F; Pappas CG; Crook T; Magafa V; Cordopatis P; Ishiguro S; Ohta N; Selent J; Bosnyak S; Jones ES; Gerothanassis IP; Tamura M; Widdop RE; Tzakos AG
ACS Chem Biol; 2014 Jul; 9(7):1420-5. PubMed ID: 24787922
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II AT2 receptor ligands with phenylthiazole scaffolds.
Gopalan G; Palo-Nieto C; Petersen NN; Hallberg M; Larhed M
Bioorg Med Chem; 2022 Jul; 65():116790. PubMed ID: 35550979
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for selectivity and diversity in angiotensin II receptors.
Zhang H; Han GW; Batyuk A; Ishchenko A; White KL; Patel N; Sadybekov A; Zamlynny B; Rudd MT; Hollenstein K; Tolstikova A; White TA; Hunter MS; Weierstall U; Liu W; Babaoglu K; Moore EL; Katz RD; Shipman JM; Garcia-Calvo M; Sharma S; Sheth P; Soisson SM; Stevens RC; Katritch V; Cherezov V
Nature; 2017 Apr; 544(7650):327-332. PubMed ID: 28379944
[TBL] [Abstract][Full Text] [Related]
9. Differential mechanisms of activation of the Ang peptide receptors AT1, AT2, and MAS: using in silico techniques to differentiate the three receptors.
Prokop JW; Santos RA; Milsted A
PLoS One; 2013; 8(6):e65307. PubMed ID: 23755216
[TBL] [Abstract][Full Text] [Related]
10. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade.
Widdop RE; Matrougui K; Levy BI; Henrion D
Hypertension; 2002 Oct; 40(4):516-20. PubMed ID: 12364356
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
12. AT1 and AT2 receptors modulate renal tubular cell necroptosis in angiotensin II-infused renal injury mice.
Zhu Y; Cui H; Lv J; Liang H; Zheng Y; Wang S; Wang M; Wang H; Ye F
Sci Rep; 2019 Dec; 9(1):19450. PubMed ID: 31857626
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-(1-9) in hypertension.
Norambuena-Soto I; Lopez-Crisosto C; Martinez-Bilbao J; Hernandez-Fuentes C; Parra V; Lavandero S; Chiong M
Biochem Pharmacol; 2022 Sep; 203():115183. PubMed ID: 35870482
[TBL] [Abstract][Full Text] [Related]
14. The Crystal Structure of Angiotensin II Type 2 Receptor with Endogenous Peptide Hormone.
Asada H; Inoue A; Ngako Kadji FM; Hirata K; Shiimura Y; Im D; Shimamura T; Nomura N; Iwanari H; Hamakubo T; Kusano-Arai O; Hisano H; Uemura T; Suno C; Aoki J; Iwata S
Structure; 2020 Apr; 28(4):418-425.e4. PubMed ID: 31899086
[TBL] [Abstract][Full Text] [Related]
15. Ligand binding determinants for angiotensin II type 1 receptor from computer simulations.
Matsoukas MT; Cordomí A; Ríos S; Pardo L; Tselios T
J Chem Inf Model; 2013 Nov; 53(11):2874-83. PubMed ID: 24090110
[TBL] [Abstract][Full Text] [Related]
16. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
[TBL] [Abstract][Full Text] [Related]
17. Using conformational constraints at position 6 of Angiotensin II to generate compounds with enhanced AT2R selectivity and proteolytic stability.
Tourwé D; Tsiailanis AD; Parisis N; Hirmiz B; Del Borgo M; Aguilar MI; Van der Poorten O; Ballet S; Widdop RE; Tzakos AG
Bioorg Med Chem Lett; 2021 Jul; 43():128086. PubMed ID: 33965531
[TBL] [Abstract][Full Text] [Related]
18. Activation of angiotensin type 2 receptor attenuates testosterone-induced hypertension and uterine vascular resistance in pregnant rats†.
Mishra JS; Kumar S
Biol Reprod; 2021 Jul; 105(1):192-203. PubMed ID: 33739377
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule AT2 receptor agonists.
Hallberg M; Sumners C; Steckelings UM; Hallberg A
Med Res Rev; 2018 Mar; 38(2):602-624. PubMed ID: 28609561
[TBL] [Abstract][Full Text] [Related]
20. Luminal ANG II is internalized as a complex with AT
Ferrão FM; Cardoso LHD; Drummond HA; Li XC; Zhuo JL; Gomes DS; Lara LS; Vieyra A; Lowe J
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F440-F449. PubMed ID: 28468964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
